Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Cell Reports|May 19, 2021
Dynamic changes to tissue-resident immunity after MHC-matched and MHC-mismatched solid organ transplantationAmy Prosser, Wen Hua Huang, Liu Liu, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 2019
Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New ZealandLuis Calzadilla-Bertot, Gary P Jeffrey, Bryon Jacques, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2020
Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver diseaseLeon A Adams, Zhengyi Wang, Chris Liddle, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 11, 2009
Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New ZealandJohn W C Chen, Lilian Kow, Deborah J Verran, et al.World Journal of Hepatology|October 1, 2024
Predictors of survival in autoimmune liver disease overlap syndromesDujinthan Jayabalan, Yi Huang, Luis Calzadilla-Bertot, et al.Cancers|June 10, 2022
Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0Savio G Barreto, Simone I Strasser, Geoffrey W McCaughan, et al.Hepatology (Baltimore, Md.)|September 26, 2020
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related CirrhosisLuis Calzadilla-Bertot, Eduardo Vilar-Gomez, Vincent Wai-Sun Wong, et al.Hepatology (Baltimore, Md.)|March 30, 2023
Predicting liver-related events in NAFLD: A predictive modelLuis Calzadilla-Bertot, Gary P Jeffrey, Zhengyi Wang, et al.Hepatology (Baltimore, Md.)|March 6, 2009
Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapySilvana Gaudieri, Andri Rauch, Katja Pfafferott, et al.Hepatology (Baltimore, Md.)|August 12, 2009
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressureAndri Rauch, Ian James, Katja Pfafferott, et al.Pageof 9